UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

With UFH dosing based on actual body weight, the dose recommended often results in under dosing in obese patients. [...]many patients may not achieve therapeutic anticoagulation in an optimal timeframe if at all.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 67; no. 13; p. 533
Main Authors: Wiggins, Barbara S, Floroff, Catherine, Grimmer, Nicole, Steinberg, Daniel, Powers, Eric
Format: Journal Article
Language:English
Published: New York Elsevier Inc 05-04-2016
Elsevier Limited
Subjects:
Angina pectoris
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Obesity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:With UFH dosing based on actual body weight, the dose recommended often results in under dosing in obese patients. [...]many patients may not achieve therapeutic anticoagulation in an optimal timeframe if at all.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30534-4